- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced or Metastatic Solid Tumor in New Zealand
Total 1919 results
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States, Puerto Rico
-
Tango Therapeutics, Inc.RecruitingLocally Advanced Solid TumorUnited States, Spain, France
-
PfizerTerminatedAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid TumorsUnited States, Canada, United Kingdom, Korea, Republic of, Australia, Belgium, Denmark, Hungary, Russian Federation
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York CityCompletedAdvanced Metastatic Cancer | Advanced Prostate CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | NF1 Mutation Positive Malignant Peripheral Nerve Sheath TumorUnited States
-
Memorial Sloan Kettering Cancer CenterLincoln Medical and Mental Health CenterRecruitingSolid Tumor | Solid Tumor, Adult | Solid Tumor, Unspecified, AdultUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterLincoln Medical and Mental Health CenterRecruitingSolid Tumor | Solid Tumor, Adult | Solid Tumor, Unspecified, AdultUnited States, Puerto Rico
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRelapsed or Refractory Solid TumorsUnited States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerNetherlands, Switzerland, Denmark, United States
-
Tango Therapeutics, Inc.RecruitingLocally Advanced Solid TumorUnited States, France
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Locally Advanced Solid Tumor | Neoadjuvant Melanoma | Head and Neck Squamous Cell Carcinoma HNSCC | HPV-associated Cancers | Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)United States, Australia, Spain, Netherlands, Korea, Republic of, Taiwan
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
-
Tyra Biosciences, IncRecruitingSolid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditionsAustralia, United States, France, Spain
-
Leap Therapeutics, Inc.Cancer Research Institute, New York CityCompletedUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor MalignanciesUnited States
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingRecurrent or Metastatic Solid TumorsUnited States
-
Karyopharm Therapeutics IncActive, not recruitingLocally Advanced Unresectable or Metastatic MelanomaUnited States
-
Alpine Immune Sciences, Inc.TerminatedLymphoma | Advanced Solid TumorUnited States, Australia
-
Proacta, IncorporatedTerminatedUnspecified Adult Solid Tumor, Protocol SpecificNew Zealand, United States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | HER2-Positive Breast CarcinomaUnited States
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
BeiGeneCompletedFor Participants With Advanced Solid Tumors Failed With Previous Lines of TreatmentAustralia
-
BeiGeneCompletedSolid TumorsAustralia, New Zealand
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
Hoffmann-La RocheCompletedSolid TumorUnited States, Korea, Republic of, Taiwan, Australia, Japan, New Zealand, China
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Canada, Taiwan
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
Berg, LLCCompletedCancer | Solid Tumor | Metastatic CancerUnited States
-
M.D. Anderson Cancer CenterVioQuest PharmaceuticalsCompletedAdvanced Cancer | Solid TumorsUnited States
-
MorphotekTerminatedMelanoma | Metastatic Melanoma | Advanced Melanoma | Malignant Metastatic MelanomaUnited States
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Yale UniversityCelgene CorporationTerminatedAdvanced Solid CancersUnited States
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorSpain, Singapore, Japan, United States, Canada
-
AbbVieCompletedAdvanced Solid Tumors CancerUnited States, Australia, Israel
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma | Advanced Solid Tumors | Metastatic Breast CancerSpain, Belgium, Italy, France, United States, New Zealand, United Kingdom
-
Roswell Park Cancer InstituteNeuroEndocrine Tumor Research Foundation (NETRF)RecruitingLung Atypical Carcinoid Tumor | Metastatic Pancreatic Neuroendocrine Tumor | Lung Typical Carcinoid TumorUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid and Hematological TP53wt TumorsFrance, Netherlands, Spain, Germany, Singapore, Japan, Taiwan, United States
-
PMV Pharmaceuticals, IncMerck Sharp & Dohme LLCRecruitingBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Metastatic Cancer | Advanced Solid Tumor | Endometrial Cancer | Metastatic Solid Tumor | Other Cancer | Advanced Malignant Neoplasm | Locally AdvancedUnited States, Spain, Korea, Republic of, Australia, France, Germany, Italy, Singapore, United Kingdom
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
AmgenCompletedAdvanced Solid TumorsCanada, United States, Belgium, Spain, Brazil, Korea, Republic of, Poland, Singapore, Taiwan, Japan, United Kingdom, Australia, Turkey
-
BayerCompletedAdvanced Solid TumorsSpain, United States, United Kingdom, Germany, Canada
-
Memorial Sloan Kettering Cancer CenterTerminatedSolid Tumor | Solid Carcinoma | Solid Tumor, ChildhoodUnited States
-
Cosmo Technologies LtdRecruitingAdvanced Refractory Solid Tumors | Subjects Considered Likely to Respond to CB-03-10United States
-
Fujifilm Pharmaceuticals U.S.A., Inc.RecruitingAdvanced Solid TumorsUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyWithdrawnUnspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | Hematopoietic/Lymphoid CancerUnited States
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
ALX Oncology Inc.Active, not recruitingSolid Tumor | Metastatic Cancer | Advanced Cancer | NonHodgkin LymphomaKorea, Republic of, United States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Excluding Breast CancerUnited States